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Summary	
The	retention	of	episodic-like	memory	is	enhanced,	in	humans	and	animals,	when	
something	 novel	 happens	 shortly	 before	 or	 after	 encoding.	 Using	 an	 everyday	
memory	task	in	mice,	we	sought	the	neurons	mediating	this	dopamine-dependent	
novelty	 effect,	 previously	 thought	 to	 originate	 exclusively	 from	 the	 tyrosine	
hydroxylase-expressing	 (TH+)	 neurons	 in	 the	 ventral	 tegmental	 area	 (VTA).	We	
report	 that	neuronal	 firing	 in	 the	 locus	 coeruleus	 (LC)	 is	 especially	 sensitive	 to	
environmental	 novelty,	 LC-TH+	 neurons	 project	 more	 profusely	 than	 VTA-TH+	
neurons	to	the	hippocampus,	optogenetic	activation	of	LC-TH+	neurons	mimics	the	
novelty	effect,	and	this	novelty-associated	memory	enhancement	is	unaffected	by	
VTA	inactivation.	Surprisingly,	two	effects	of	LC-TH+	photoactivation	are	sensitive	
to	hippocampal	D1/D5	receptor	blockade	and	resistant	to	adrenoceptor	blockade	–	
memory	enhancement	and	 long	 lasting	potentiation	of	 synaptic	 transmission	 in	
CA1	 ex	 vivo.	 Thus,	 LC-TH+	 neurons	 can	 mediate	 post-encoding	 memory	
enhancement	 in	 a	 manner	 consistent	 with	 possible	 co-release	 of	 dopamine	 in	
hippocampus.	
	
	 Studies	of	memory	for	over	a	century1	indicate	that	there	is	substantial	forgetting	within	a	day2.	Everyday	memory	includes	many	episodic-like	memories	that	we	may	form	automatically3,4.	Most	are	forgotten,	others	retained	for	longer	such	that	they	can	then	be	subject	to	stabilisation	in	the	neocortex	via	systems	consolidation5,6.	Initial	retention	occurs	when	something	novel	or	categorically	relevant	happens	shortly	before	or	after	the	time	of	memory	encoding,	as	in	‘flashbulb	memory’7,8.	Prospective	studies	of	novelty-associated	enhancement	of	retention	in	animals	point	to	possible	mechanisms9-14,	one	suggestion	being	that	a	novelty	signal	from	VTA	to	the	hippocampus	is	causally	important15,16.	Pharmacological	studies	of	protein	synthesis-dependent	long-term	potentiation	and	depression	(LTP/LTD)	support	the	concept	of	dopamine	(DA)-dependent	enhancement	of	persistence13,17-19,	but	do	not	identify	the	neuronal	source	of	DA.	We	anticipated	that	tyrosine	hydroxylase	positive	neurons	in	VTA	(VTA-	TH+)	would	be	critical,	but	the	possibility	that	LC-TH+	neurons	can	sometimes	release	DA	as	well	as	noradrenaline	(NA)20-22	led	to	our	broadening	the	project	to	include	LC-TH+	as	well	as	VTA-TH+	neurons.		
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Novelty	enhances	memory	persistence	We	used	120	mice	and	began	by	checking	that	enhancement	of	memory	retention	by	environmental	novelty,	previously	shown	in	rats12,13,	could	also	be	observed	in	mice.	This	involved	our	‘everyday’	memory	task	-	a	model	for	‘episodic-like’	or	‘one-shot’	memory23	-	using	a	smaller	arena	for	mice	who	searched	for	food	reward	in	one	of	23	different	sandwells	whose	location	varied	across	days	(Fig.	1a,	Extended	Data	Fig.	1a).	Male	Th-Cre	mice	encoded	the	changing	daily	location	of	reward	in	‘sample’	trials	and	learned	to	display	effective	memory	in	later	daily	‘choice’	trials	(5	sandwells).	The	data,	plotted	as	a	5-alternative	forced-choice	performance	index	(PI),	revealed	stable	choice	performance	(circa	80%)	across	weeks	of	testing	(Fig.	1a,	Extended	Data	Fig.	1b,c).	A	control	test	(sessions	61-65)	established	the	absence	of	olfactory	artefacts.	Memory	was	tested	using	a	counterbalanced	series	of	occasional	unrewarded	probe	tests	(PTs)	that	sometimes	followed	the	sample	trial(s)	at	different	intervals.	Reward	availability	on	sample	trials	(memory	encoding)	was	varied	(low	and	high	reward).	Effective	memory	at	1h	(memory	retrieval)	was	displayed	in	PTs	for	even	the	smallest	reward,	but	forgetting	across	24h	showed	an	inverse	relationship	with	reward	magnitude	(Fig.	1b,	Extended	Data	Fig.	1d).	A	key	finding	was	that	unexpected	novelty	for	5min	-	exploration	of	a	box	with	an	unfamiliar	floor	surface	placed	inside	the	event	arena	30min	after	the	encoding	trial	-	prolonged	spatial	memory	to	24h	(Fig.	1b).	This	post-encoding	novelty	was	environmental	and	not	a	change	in	reward	expectancy.		
Fig. 1 here 		 Memory	retention	in	this	task	is	impaired	by	a	drug	targeting	D1/D5	receptors	in	hippocampus	in	rats13.	In	our	mice,	the	D1/D5	receptor	antagonist	SCH23390	(SCH)	blocked	novelty-induced	enhancement	of	memory	persistence,	whereas	the	b-adrenoceptor	antagonist	propranolol	(Prop)	had	no	effect	(Fig.	1c,	Extended	Data	Fig.	1e).		
TH+	neurons	show	a	novelty	response	The	next	step	was	to	identify	if	TH+	neurons	are	activated	by	environmental	novelty.	Th-Cre	mice	were	given	stereotaxic	injections	of	a	Cre-inducible	adeno-associated	virus	(AAV)	carrying	Channelrhodopsin-2	(ChR2)	fused	to	enhanced	yellow	fluorescent	protein	(eYFP)	into	the	VTA	or	LC	and	implanted	with	an	‘optetrode’	(Fig.	
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2a,	Extended	Data	Fig.	2).	Several	weeks	later,	brief	low	frequency	blue	light	illumination	was	used	to	identify	ChR2-eYFP-positive	neurons	in	awake	mice.	TH+	neurons	were	identified	(Fig.	2a,	Extended	Data	Fig.	3a,b),	and	recording	then	continued	without	light	pulses	as	the	mice	explored	both	familiar	(regular	visits)	and	novel	chambers	(rare	visits,	each	visit	with	a	novel	floor	surface)	for	5min	in	a	counterbalanced	sequence	(Fig.	2b).	Representative	raster	plots	show	novelty	affected	light-responsive	neurons	in	both	VTA	and	LC	(Fig.	2c),	with	increased	firing	rates	in	most	VTA-TH+	(12/15	neurons)	and	all	LC-TH+	(10/10)	neurons	(Fig.	2d).	Firing	rate	modulation	was	quantitatively	larger	for	LC-TH+	neurons,		above	the	usual	tonic	firing	rate24,	and	it	habituated	monotonically	over	time	(Fig.	2e,	Extended	Data	Fig.	3c;	Ref25).	VTA-TH+	and	LC-TH+	neurons	showed	more	frequent	bursts	in	novel	environments	with	a	within-burst	spike	frequency	of	12.8	to	53.4Hz	(Extended	Data	Fig.	3d,e).	This	bursting	pattern	was,	by	design,	used	to	determine	an	effective	optogenetic	stimulation	protocol	for	both	in	vivo	and	ex	vivo	experiments.			
Fig. 2 here 
LC	projects	extensively	to	hippocampus	Previous	retrograde	tracing	and	immunohistochemical	work	in	the	rat	has	shown	that	only	a	subset	of	VTA	afferents	to	the	hippocampus	are	dopaminergic26.	Our	cell-type	specific	anterograde	tracing	revealed	a	paucity	of	projections	from	VTA-TH+	neurons	to	dorsal	hippocampus,	but	substantial	projections	from	LC-TH+	neurons	(Fig.	3a–f).	This	involved	unilateral	injection	of	the	Cre-inducible	eYFP	virus	into	VTA	or	LC	of	Th-Cre	mice.	Most	TH+	neurons	in	VTA	and	LC	expressed	eYFP	(Extended	Data	Fig.	2g).	We	first	established	co-localisation	of	TH	in	eYFP+	axons	in	the	dorsal	hippocampus	(Fig.	3b,d	–	top	panels),	and	then	co-localisation	of	eYFP,	TH	and	the	noradrenergic	transporter	(NET)	for	LC-axons	but	not	VTA-axons	(Fig.	3b,d	–	bottom	panels;	Extended	Data	Fig.	4).	We	quantified	eYFP+	axons	projecting	to	hippocampus,	calculating	both	the	area	occupied	by	all	eYFP-TH	double-positive	axons	and	the	ratio	of	double-positive	axons	relative	to	all	TH+	axons	(Fig.	3e,f).	An	overwhelming	proportion	of	axons	came	from	LC-TH+	neurons	with	very	few	from	VTA-TH+	neurons	(see	also	Ref21).	Retrograde	tracing	with	fluorescent	retrobeads	from	dorsal	hippocampus	confirmed	minimal	transport	to	VTA,	but	double-labelled	neurons	in	LC	(retrobeads	and	TH-positivity;	Extended	Data	Fig.	5)	
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Fig. 3 here 
 
LC	activation	mimics	the	novelty	effect	The	overarching	aim	of	this	project	was	to	identify	neuromodulatory	neurons	whose	post-encoding	firing	promotes	the	consolidation	of	hippocampal-dependent	memory.	The	data	so	far	pointed	to	the	need	to	change	our	focus	to	LC-TH+	neurons	as	likely	mediators	of	environmental	novelty,	retaining	a	check	on	the	impact	of	activating	VTA-TH+	neurons.	Th-Cre	mice	were	stereotaxically	prepared	with	bilateral	injections	of	the	ChR2-eYFP	(ChR2+)	or	a	no	opsin	control	(eYFP)	virus	(ChR2–),	accompanied	by	implantation	of	bilateral	optic	cannulae	into	both	LC	and	VTA	and	bilateral	drug	cannulae	targeting	dorsal	hippocampus	(Fig.	4a).	An	optimum	optogenetic	burst	stimulation	frequency	of	25Hz	was	chosen	(Fig.	4b)	based	on	our	within-burst	firing	data	and	both	LC-TH+	and	VTA-TH+	neurons	could	follow	this	frequency	in	awake	mice	(Extended	Data	Figs.	3e,6a).	After	training	to	a	performance	index	of	circa	75%,	these	mice	showed	effective	memory	in	a	10-min	probe	test	(Extended	Data	Fig.	6b,c).	The	stage	was	then	set	for	examining	whether	5min	optogenetic	burst	activation,	scheduled	30min	after	memory	encoding,	could	mimic	the	beneficial	effects	of	environmental	novelty	on	memory	retention	at	24h	(Fig.	4c).	The	key	finding	was	the	striking	persistence	of	memory	over	24h	when	5min	of	post-encoding	(30min)	intermittent	burst	stimulation	of	LC-TH+	neurons	with	blue	light	was	given	to	the	ChR2+	mice	in	their	home	cages.	Tested	24h	after	weak	memory	encoding,	LC	activated	ChR2+	animals	remembered	the	location	of	the	sample	sandwell	sampled	30min	prior	to	light	activation	(Fig.	4d	left;	ChR2+	in	LC-ON).	Memory	for	24h	was	not	observed	without	LC	light	stimulation	(ChR2+	in	OFF),	nor	in	separate	ChR2–	controls.	Light-activation	of	VTA,	in	the	same	ChR2+	animals,	induced	only	a	non-significant	trend	favouring	some	memory	at	24h,	but	we	observed	a	similar	trend	in	ChR2–	mice	(Fig.	4d	right,	compare	ChR2+	and	ChR2–	in	VTA-ON).	Not	only	did	these	upwards	trends	not	differ	from	chance,	they	also	did	not	differ	from	each	other,	suggesting	that	the	trend	is	unrelated	to	light-activation	of	ChR2-positive	neurons	in	VTA	(e.g.	light-induced	temperature	changes27).		
Fig. 4 here   
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	We	were	therefore	confronted	by	the	paradox	that	light	activation	of	LC	enhances	retention	(Fig.	4d)	but	intrahippocampal	infusion	of	a	D1/D5	receptor	antagonist	during	behavioural	novelty	blocks	it	(Fig.	1c).	Accordingly,	we	examined	the	impact	of	post-encoding	microinfusion	of	catecholaminergic	antagonists	into	the	hippocampus	during	optogenetic	activation	of	LC	(Fig.	4e).	We	confirmed	that	light	activation	of	LC	in	ChR2+	mice	enhanced	24-h	spatial	memory	(Fig.	4f;	ChR2+	in	LC-ON	with	vehicle)	but	this	enhancement	was	blocked	by	intrahippocampal	infusion	of	SCH	(ChR2+	in	LC-ON	with	SCH)	but	not	by	Prop	(ChR2+	in	LC-ON	with	Prop;	see	also	Extended	Data	Fig.	6d).	This	raises	the	possibility	of	LC-TH+	terminals	co-releasing	DA	in	hippocampus,	or	of	heterodimerization	between	NA	and	DA	receptors.		
LC	activation	enhances	synaptic	efficacy	To	explore	one	possible	mechanism	of	this	enhancement	of	memory	retention,	ex	
vivo	electrophysiological	experiments	examined	the	response	of	CA1	pyramidal	neurons	to	CA3	Schaffer	collateral	synaptic	input	(Fig.	5a).	Three	weeks	before	obtaining	the	slices,	bilateral	injections	of	a	Cre-inducible	ChR2-eYFP	virus	were	made	into	LC	of	Th-Cre	mice	(Extended	Data	Fig.	7a),	in	keeping	with	the	recently	described	‘output-defined	elements’	concept28.	Following	three	trains	of	burst	optogenetic	stimulation	of	hippocampal	LC-TH+	axons	(Extended	Data	Fig.	7b),	the	CA3-CA1	excitatory	postsynaptic	currents	(EPSCs)	gradually	increased	by	55%	over	~30min	(Fig.	5b,	Light-ON),	an	increase	unaffected	by	the	presence	of	the	a-	and	b-adrenoceptors	antagonists,	prazosin	(Praz)	and	Prop.	In	contrast,	there	was	no	increase	following	optogenetic	LC-TH+	activation	in	the	presence	of	SCH,	revealing	a	pattern	of	EPSC	potentiation	consistent	with	mediation	by	a	dopaminergic	mechanism.	 		
Fig. 5 here   	LTP	at	CA3-CA1	synapses	was	then	examined	using	theta-burst	stimulation	to	induce	LTP.	Hippocampal	LC-TH+	axons	were	selectively	activated	with	a	protocol	closely	mimicking	LC-TH+	firing	patterns	recorded	during	novelty	exploration	(Extended	Data	Fig.	7c).	LTP	differed	in	magnitude	across	4	conditions	(Fig.	5c).	Theta-
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burst	stimulation	alone	induced	LTP	by	29%	at	45min	(Light-OFF	+	LTP)	relative	to	a	no-LTP	baseline;	by	59%	when	combined	with	optogenetic	LC-TH+	activation	(Light-ON	+	LTP);	but	by	was	blocked	by	SCH	(Light-ON	+	LTP	with	SCH).	Taken	together,	these	findings	indicate	that	depolarisation	of	hippocampal	LC-TH+	axons	by	optogenetic	stimulation	can	enhance	synaptic	transmission,	and	that	a	physiologically	realistic	pattern	potentiates	LTP	at	CA3-CA1	synapses	in	a	manner	consistent	with	release	of	DA	from	hippocampal	LC-TH+	terminals.		
VTA	blockade	has	no	impact	on	novelty	effect	Last,	we	attempted	to	block	LC-TH+	neurons	during	novelty	to	see	if	memory	enhancement	disappeared.	Acute	electrophysiological	studies	showed	that	firing	of	LC-TH+	neurons	expressing	archaerhodopsin	(eArch3.0)-eYFP	could	be	successfully	inhibited	by	light	over	5min	(Extended	Data	Fig.	8).	Unfortunately,	TH+	neurons	always	displayed	a	substantial	‘rebound’	of	firing	when	the	light	was	turned	off29.	Were	this	rebound	to	occur	in	a	behavioural	study	of	memory,	the	rebound	would	likely	overcome	the	earlier	5min	period	of	neuronal	quiescence.		
Fig. 6 here   		 At	this	point,	we	had	Th-Cre	mice	expressing	eArch3.0-eYFP	or	eYFP	in	LC	trained	with	comparable	levels	of	task	performance	to	those	of	the	earlier	experiments	(Extended	Data	Fig.	9a,b).	While	we	were	unable	to	use	eArch3.0,	the	mice	had	bilateral	drug	cannulae	targeting	VTA.	In	separate	acute	electrophysiology	experiments,	sodium	channel	blocker	lidocaine	successfully	inhibited	VTA	neuronal	firing	(Fig.	6a).	We	therefore	examined	the	impact	of	intra-VTA	infusion	of	lidocaine	during	novelty	exploration.	As	expected,	novelty	enhancement	was	maintained	(Fig.	6b,	Extended	Data	Fig.	9c).	The	novelty	effect	was,	however,	sensitive	to	the	a2-adrenoceptor	agonist	clonidine	(Fig.	6c,	Extended	Data	Fig.	9c)	that	inhibits	LC	neurons30	(personal	communication	with	O.Eschenko,	MPI-Tuebingen).	The	mice	were	given	a	series	of	counterbalanced	probe	tests.	One	test	showed	normal	forgetting	over	24h	with	low-reward	encoding	(No	novelty	with	Vehicle),	another	the	usual	enhanced	retention	induced	by	environmental	novelty	(Novelty	with	Vehicle).	Critically,	systemic	clonidine	blocked	the	effect	of	novelty	on	24h	memory	retention	(Novelty	with	Clonidine).			
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Discussion		 This	study	sought	to	identify	neuromodulatory	neurons	that,	in	response	to	environmental	novelty,	trigger	intracellular	signal-transduction	cascades	within	hippocampal	neurons	responsible	for	the	initial	consolidation	of	everyday	memory15,31,32.	Lisman	and	Grace15	proposed	that	novelty-associated	enhancement	of	hippocampal-dependent	memory	was	mediated	by	a	subiculum-accumbens-pallidal-VTA-CA1	pathway,	an	idea	supported	by	both	animal	and	human	studies33.	Our	data	indicate,	however,	that	VTA-TH+	neurons	display	weak	anatomical	connectivity	with	hippocampus,	are	only	slightly	activated	by	environmental	novelty,	and	their	pharmacological	blockade	during	novelty	has	no	effect	on	memory	enhancement.	In	contrast,	LC-TH+	neurons	are	more	responsive	to	environmental	novelty,	show	habituation	of	enhanced	firing	over	5min,	have	extensive	connectivity	with	hippocampus,	and	display	post-encoding	optogenetic	activation	that	successfully	enhances	memory	retention.	Clonidine,	which	decreases	neuronal	activity	in	LC30	but	not	in	VTA34,	prevents	this	novelty	effect.	At	the	synaptic	level	ex	vivo,	selective	optogenetic	activation	of	LC-TH+	axons	in	hippocampus	mediates	a	D1/D5	receptor-sensitive	enhancement	of	synaptic	transmission	and	electrically	evoked	LTP	at	CA3-CA1	synapses,	consistent	with	the	idea	that	LC-TH+	neurons	might	co-release	DA20,21.	Transmitter	co-release	of	glutamate	and	GABA	from	TH+	neurons	has	been	reported	(substantia	nigra	(SN)/VTA-TH+	terminals35,36).	Lisman	and	colleagues	have	modified	their	model	to	recognise	this	possibility37,	rescuing	DA	receptor-dependence	at	the	expense	of	recognising	a	different	circuit	for	mediating	the	impact	of	environmental	novelty	on	hippocampal	memory.			 Importantly,	environmental	novelty	differs	from	changes	in	reward	expectancy	or	magnitude.	Reward	expectancy	is	a	critical	component	of	the	execution	of	learned	actions	until	they	become	habitual38.	Longstanding	data	point	to	the	role	of	SN/VTA	system	in	processing	unexpected	reward	in	striatal39-41	and	hippocampal	tasks42.	Activation	of	VTA-TH+	axons	can	bidirectionally	modulate	CA3-CA1	synaptic	responses	
ex	vivo43,	but	in	our	in	vivo	study,	post-encoding	VTA-TH+	activation	was	without	a	behavioural	effect.	Environmental	novelty	is	when	something	unexpected	happens	unrelated	to	reward	during	ongoing	behaviour.	It	is	likely	to	affect	a	distinct	neuromodulatory	system,	but	one	with	extensive	connectivity	to	the	hippocampus	
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where	it	could	activate	memory	processes	including	the	synthesis	and	capture	of	plasticity-related	proteins31.	In	this	way,	unexpected	environmental	novelty	could	enhance	memory	retention.		The	noradrenergic	system	of	the	LC,	with	its	diverse	projections	to	numerous	brain	areas44	has	long	been	implicated	in	novelty,	arousal	and	cognition24,45,46	and	its	firing	is	tied	to	distinct	up	and	down	states	during	sleep47.	It	appears	that	the	time	over	which	LC	neurons	exert	their	effects	is	much	less	precise	than	for	VTA,	in	keeping	with	the	synaptic	tagging-and-capture	hypothesis48-50.	This	hypothesis	has	functional	implications	that	extend	well	beyond	the	domain	of	LTP,	affecting	the	retention	of	events	via	neural	activity	happening	before	and	after	the	precise	moment	that	encoding	occurs	(as	in	flashbulb	memory7).	In	this	way,	the	retention	of	everyday	experience	is	modulated	over	time	and	not	just	at	the	precise	moment	that	individual	events	are	encoded.		 	
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Methods	
Animals			The	subjects	were	Th-Cre	knock-in	heterozygous	male	mice	backcrossed	more	than	20	times	to	the	C57BL/6	strain	(Thtm1(cre)Te;	EM:00254)51	(behavioural	and	anatomical	studies,	n	=	71	mice),	Th-Cre	transgenic	heterozygous	male	mice	on	a	mixed	C57BL/6	and	CD1	background	[Tg(Th-cre)1Tmd]52	(for	ex	vivo	hippocampal	electrophysiology,	n	=	42),	and	C57BL/6	male	mice	(Charles	River;	n	=	7).	They	were	>	8	weeks	old	at	the	start	of	the	experiments,	several	of	which	continued	for	many	months.	All	mice	were	given	water	ad	libidum,	kept	under	a	12	h	light/dark	cycle	(lights	on	7:00	am);	given	food	ad	libidum	in	unit	recording	studies	but	food-restricted	for	event	arena	training	(85%	of	free-feeding	weight	monitored	daily	throughout	the	study,	after	behavioural	training).	Behavioural	testing	was	carried	out	during	the	light	phase	of	the	cycle.	All	procedures	were	overseen	by	the	University	of	Edinburgh	Ethical	Review	Committee,	compliant	with	the	UK	Animals	(Scientific	Procedures)	Act	1986	and	with	the	European	Communities	Council	Directive	of	24	November	1986	(86/609/EEC)	legislation	governing	the	maintenance	of	laboratory	animals	and	their	use	in	scientific	experiments;	and	with	guidelines	of	the	Animal	Welfare	Committee	of	Hokkaido	University;	were	approved	by	the	animal	care	and	use	committee	(IACUC)	at	the	University	of	Texas	Southwestern	Medical	Center	and	comply	with	federal	regulations	set	forth	by	the	National	Institutes	of	Health.	
	
Viral	vectors	The	Cre-inducible	AAV	were	obtained	from	the	University	of	North	Carolina	(UNC)	Vector	Core	Facilities.	The	viral	concentration	was	8.0	×	1012	particles	ml–1	for	AAV5/EF1a-DIO-hChR2(H134R)-eYFP	(ChR2-eYFP),	3.2	×	1012	particles	ml–1	for	AAV5/EF1a-DIO-eArch3.0-eYFP	(eArch3.0-eYFP),	4.0	×	1012	particles	ml–1	for	AAV5/EF1a-DIO-eNpHR3.0-eYFP	(eNpHR3.0-eYFP),	4.0	×	1012	particles	ml–1	for	AAV5/EF1a-DIO-eYFP	(eYFP	control),	and	1-7	×	1012	particles	ml–1	for	AAV2/EF1a-DIO-hChR2(H134R)-eYFP	(for	ex	vivo	hippocampal	electrophysiology).	Virus	were	subdivided	into	aliquots	stored	at	–80°C	until	use.	
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Stereotactic	surgery	Anaesthesia	was	induced	using	isoflurane	(induction,	5%;	maintenance,	1-2%;	air-flow,	1	l	min–1).	The	animals	were	placed	in	the	stereotactic	frame	(Kopf	Instruments).	For	viral	or	retrobead	(Lumafluor)	injection,	a	small	hole	was	drilled	into	the	skull	over	the	target	site.	The	virus	(0.75-1	µl)	or	retrobead	solution	(0.1	µl)	was	then	injected	at	0.1	µl	min–1	into	the	target	site	using	a	Nanofil	syringe	(WPI)	and	UMP3	pump	(WPI)	mounted	directly	on	the	stereotactic	frame.	After	injection,	a	needle	of	the	syringe	was	left	for	10	min	to	reduce	back-flow	and	then	withdrawn	slowly.	Animals	recovered	on	a	heating	pad	until	normal	behaviour	resumed.	All	experiments	involving	viral	constructs	were	performed	at	least	3	weeks	after	surgery	in	order	to	allow	for	sufficient	expression.	Viral	infusion	coordinates	were:	VTA	[from	bregma53:	anterior-posterior	(AP),	–3.50	mm;	mediolateral	(ML),	0.50	mm;	and	dorsal-ventral	(DV)	from	the	dura,	–4.40	mm]	]	and	LC	(AP,	–5.45	mm;	ML,	1.20	mm;	and	DV,	–3.65	mm).	
Event	arena	pharmacological	experiment	(Fig.	1):	Bilateral	26-gauge	microinjection	steel	guide	cannulae	(2.5	mm	length,	3.0	mm	distance	between	cannulae;	Plastics	One)	with	stylets	that	protruded	0.5	mm	below	the	end	of	the	cannula	(33	gauge,	Plastics	One)	were	then	implanted	into	the	dorsal	hippocampus.	The	cannula	implantation	co-ordinates	were	(AP,	–2.10	mm;	ML,	±1.50	mm;	and	DV,	–2.00	mm).	
Extracellular	recording	in	a	novelty	exploration	paradigm	(Fig.	2):	the	Cre-inducible	AAV5	ChR2-eYFP	virus	(1	µl)	was	unilaterally	injected	into	VTA	or	LC	as	mentioned	above.	Four	jeweller’s	screws	were	then	placed	in	the	skull	and	the	ground	wire	was	attached	to	one	of	the	skull	screws.	The	microdrive	implantation	co-ordinates	were:	VTA	(AP,	–3.52	mm;	ML,	0.48	mm;	and	DV,	–4.00	mm)	and	LC	(AP,	–5.45	mm;	ML,	1.00	mm;	and	DV,	–2.80	mm).	Adhesive	cement	(C&B	metabond,	Parkell)	and	dental	acrylic	were	then	sculpted	around	the	microdrive.	
Tract	tracing	experiment	(Fig.	3,	Extended	Data	Fig.	5):	For	anterograde	tracing,	the	Cre-inducible	AAV5	eYFP	virus	(1	µl)	was	unilaterally	injected	into	VTA	or	LC	as	described	above.	For	retrograde	tracing,	retrobeads	(0.1	µl)	were	unilaterally	injected	into	CA1	(AP,	–2.18	mm;	ML,	1.18	mm;	and	DV,	–1.36	mm),	CA3	(AP,	–2.18	mm;	ML,	2.68	mm;	and	DV,	–2.05	mm)	and	DG	(AP,	–2.18	mm;	ML,	1.36	mm;	and	DV,	–1.82	mm).		
Event	arena	experiment	with	optogenetics	(Fig.	4):	Arterial	oxygen	saturation,	heart	rate	and	breath	rate	were	monitored	by	MouseOx	instrument	(STARR	Life	Science).	The	Cre-inducible	AAV5	virus	(ChR2-eYFP	or	eYFP,	1	µl	per	side)	was	injected	bilaterally	into	
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VTA	and	LC	according	to	the	procedure	described	above.	A	dual	ferrule	optical	fibre	implant	(0.22	NA,	200	µm	core	diameter;	Doric	Lenses)	was	implanted	vertically	into	VTA	(AP,	–3.40	mm;	ML,	±0.50	mm;	and	DV,	–4.30	mm).	Subsequently,	a	two-ferrule	optical	fibre	implant	(0.22	NA,	200	µm;	Doric	Lenses)	was	implanted	into	LC	at	–30°	angle	to	coronal	plane	(AP,	–5.45	mm;	ML,	±0.90	mm;	and	DV,	–3.00	mm).	Additionally,	bilateral	26-gauge	steel	guide	cannulae	(4.0	mm	length,	3.0	mm	distance	between	cannulae)	with	stylets	(33	gauge)	that	protruded	0.5	mm	below	the	end	of	the	cannula	was	inserted	into	the	dorsal	hippocampus	at	a	40°	angle	to	coronal	plane	(AP,	–2.10	mm;	ML,	±1.50	mm;	and	DV,	–2.00	mm).	
Event	arena	experiment	with	pharmacological	inactivation	(Fig.	6):	The	Cre-inducible	AAV5	virus	(eArch3.0-eYFP	or	eYFP,	1	µl	per	side)	was	injected	bilaterally	into	LC,	and	a	two-ferrule	optical	fibre	implant	was	then	implanted	into	LC	at	–30°	angle	to	coronal	plane	as	described	above.	Additionally,	bilateral	26-gauge	steel	guide	cannulae	(4.8	mm	length,	1.0	mm	distance	between	cannulae)	with	stylets	(33	gauge)	that	protruded	0.5	mm	below	the	end	of	the	cannula	was	inserted	into	VTA	(AP,	–3.40	mm;	ML,	±0.50	mm;	and	DV,	–4.40	mm).	
Ex	vivo	hippocampal	electrophysiology	(Fig.	5):		The	Cre-inducible	AAV2	ChR2-eYFP	virus	(0.75-1	µl	per	side)	was	bilaterally	injected	into	LC	(AP,	–5.45	mm;	ML,	±0.90	mm;	and	DV,	–3.00	mm)	over	a	10-15	min	period	using	a	borosilicate	glass	electrode	(10-15	MΩ)	pulled	with	a	horizontal	pipet	puller	(P-97,	Sutter	Instrument)	and	a	picospritzer	(Parker)	timed	by	a	Master-8	pulse	stimulator	(A.M.P.I.).	After	each	injection,	the	pipette	was	kept	in	place	for	5	min	to	ensure	proper	diffusion	of	the	virus.		
Postoperative	analgesia:	Carprofen	(0.08	ml	kg–1	body	weight),	or	buprenorphine	(0.1	mg	kg–1	body	weight),	was	administered	by	subcutaneous	injection	at	the	end	of	all	surgical	procedures.	All	mice	were	allowed	a	recovery	period	of	at	least	7	days	in	order	for	them	to	regain	their	pre-surgery	weights	before	electrophysiological	or	behavioural	testing.		
Everyday	memory	apparatus	Everyday	memory	was	tested	in	an	event	arena	–	a	square	open	field	(120	cm	wide	×	120	cm	long)	with	walls	(35	cm	high)	made	out	of	transparent	Plexiglas	(Fig.	1a)	with	4	adjacent	start	boxes	(black	plexiglass).	The	name	‘event	arena’	derives	from	it	being	an	arena	in	which	‘events’	happen	(e.g.	finding	food)13.	The	floor	of	the	arena,	arranged	in	a	5	×	5	grid,	was	covered	with	~2	cm	of	sawdust	and	had	two	intramaze	landmarks	(a	
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white	metal	cube	located	at	row	3,	column	2,	and	a	black	rubber	flash	light	at	row	3,	column	4).	The	Plexiglas	sandwells,	in	which	food	reward	was	potentially	available,	could	be	fitted	into	any	of	the	23	remaining	sandwell	positions	(positions	occupied	by	internal	cues	were	excluded).	The	mice	had	access	to	the	arena	and	sandwells	when	the	startbox	door	was	opened	in	any	trials.	Light	levels,	checked	every	day,	were	25-35	lux.	Data	was	recorded	using	custom-made	LabVIEW	software	(National	Instruments),	using	the	image	from	camera	placed	above	the	arena.			
Novelty	apparatus	For	novelty	exploration,	a	square	Plexiglas	open	field	with	transparent	walls	(70	cm	wide	×	70	cm	long	×	30	cm	high)	was	placed	in	the	middle	of	the	event	arena	(Fig.	1b).	In	order	to	maintain	the	novelty	of	the	environment,	a	wide	range	of	floor	substrates	(dried	leaves,	shredded	paper,	feathers,	acrylic	pompoms,	corks,	lolly	sticks,	Lego	blocks,	pipe	cleaners,	shredded	straws,	and	sea	shells)	that	covered	the	floor	of	the	box	were	used,	as	in	a	previously	published	protocol	that	used	rats13.	
	
Event	arena	tasks	
Sample	size,	randomization,	blinding	and	replication:	A	distinctive	feature	of	event	arena	tasks	is	that	most	but	not	all	comparisons	are	‘within-subjects’	design	in	which	every	single	subjects	are	exposed	to	every	single	treatment,	including	the	control	treatment.	This	typically	reduces	the	number	of	subjects	required	for	statistical	significance	and	avoids	issues	associated	with	randomization.	All	non-rewarded	probe	tests	(see	below)	were	analysed	blind	and,	being	conducted	against	a	stable	performance	background,	were	typically	conducted	twice	or	three	times	(internal	replication).	Averaging	data	helped	reduce	variability.	
Shaping	and	habituation:	After	handling,	habituation	(8	sessions)	involved	training	mice	to	dig	in	the	sandwells	to	retrieve	food	(a	half	of	cereal	‘cheerios’)	and	carry	it	to	the	start	box.	
Everyday	training	protocol:	The	goal	in	each	daily	session	was	to	encode	the	changing	daily	location	of	a	rewarded	sandwell	encountered	during	two	consecutive	sample	trials	(2	retrievals	of	buried	food	in	each	trial),	and	then,	10	min	later,	return	to	that	same	location	during	the	choice	trial	(Fig.	1a).	The	choice	trial	was	a	retrieval	test	that	involved	a	rewarded	sandwell	in	a	location	that	matched	the	sample	location	(the	
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“correct”	location;	win-stay	rule)	and	4	non-rewarded	sandwells	placed	in	other	locations	around	the	arena	(the	“incorrect”	locations).	Training	sessions	were	conducted	daily	(5-7	sessions	per	week)	using	16	different	sandwell	configurations	with	rewarded	sandwell	positions	counterbalanced	between	mice	(Extended	Data	Fig.	1a).	We	calculated	a	performance	index	(PI),	using	a	formula	PI=100–[100×(errors/4)],	based	on	the	number	of	errors	made	during	the	choice	trial	(an	error	being	digging	at	an	incorrect	sandwell).	The	value	expected	based	on	chance	was	50%	(2	errors).	With	each	behavioural	cohort,	we	began	conducting	critical	memory	probe	tests	once	mice	reached	average	performance	index	of	75%	(equivalent	to	1	error,	computed	as	average	of	last	5	training	sessions).	This	typically	happened	within	35	training	sessions,	but	sometimes	additional	training	was	needed	due	after	complex	surgical	procedures.			
Memory	probe	tests:	The	primary	data	measure	of	the	study	were	derived	from	‘memory	tests’	performed	as	‘probe’	tests	–	a	session	in	which	none	of	the	sandwells	contained	any	accessible	food	pellets.	The	mice	were	cued	with	a	food	pellet	in	the	start	box,	and	then	allowed	to	search	for	the	correct	sandwell	for	60	s	from	the	first	dig	of	any	sandwell.	After	60	s,	the	experimenter	quietly	entered	the	room	and	buried	pellets	in	the	correct	sandwell,	allowing	the	mouse	to	retrieve	them	(one	by	one	as	in	training,	this	limited	‘extinction’).	Dig	time	at	each	sandwells	was	measured,	and	the	relative	proportion	of	time	at	the	correct	and	incorrect	sandwells	was	calculated.	The	value	expected	based	on	chance	was	20%.	Probe	tests	were	always	separated	by	at	least	2	sessions	of	regular	training.	In	the	‘reward	magnitude’	probe	tests	(Fig.	1b,	Extended	Data	Fig.	1d),	animals	retrieved	either	two	pellets	(low	reward)	or	eight	pellets	(high	reward)	during	memory	encoding.		
Novelty	exploration:	The	mice	underwent	7	sessions	of	habituation	to	the	box	with	sawdust	placed	in	the	event	arena.	For	post-encoding	unexpected	environmental	novelty,	the	mouse	was	placed	into	the	centre	of	the	box	lined	with	a	novel	substrate	and	allowed	to	explore	freely	for	5	min.		
	
Behavioural	pharmacology		
Microinfusion/injection	of	drugs:		To	help	reduce	any	stress,	all	drugs	were	infused	in	the	home	cages.	The	stylets	in	the	guide	cannulae	were	replaced	by	a	double	infusion	cannula	(33	gauge,	Plastics	One)	connected	to	two	5	µl	microsyringes	(WPI)	in	a	microinfusion	pump	(Native	Instruments)	via	flexible	plastic	tubing	(C232CS,	Plastics	One)	filled	with	Fluorinert	(3M).	The	tips	of	infusion	cannulae	projected	0.5	mm	below	
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the	tip	of	the	guide	cannulae.	For	intra-hippocampal	microinjection,	0.5	µl	of	drug	per	cannula	was	infused	at	0.2	µl	min–1	(2.5	min).	Infusion	cannulas	were	left	in	place	for	a	further	2.5	min	before	being	replaced	with	stylets	to	aid	drug	absorption.	For	intra-VTA	microinjection,	0.3	µl	was	injected	at	a	rate	of	0.3	µl	min–1	(1	min)	followed	by	1-min	of	waiting.	The	mice	were	habituated	to	the	experimental	procedure	of	injection	and	to	vehicle	injection	prior	to	the	drug	test	in	order	to	minimize	novelty	effect.	Mice	received	drug	injection	20	min	(hippocampal	microinfusions	and	i.p.	injection	of	clonidine)	or	3	min	(VTA	microinfusions)	prior	to	the	novelty	exploration.	
Drug	concentrations:	For	microinfusions,	the	concentrations	used	were	21.1	mM	(6.25	µg	µl–1)	for	b-adrenoceptor	antagonist	propranolol	[(S)-(–)-propranolol	hydrochloride,	295.80	g	mol–1;	Sigma-Aldrich),	3.1	mM	(1	µg	µl–1)	for	D1/D5	receptor	antagonist	SCH23390	(SCH	23390	hydrochloride,	324.24	g	mol–1;	Tocris)	and	2%	w/v	for	voltage-gated	sodium	channel	blocker	lidocaine	(lidocaine	hydrochloride	monohydrate,	288.81	g	mol–1;	Sigma-Aldrich).	a2-adrenoceptor	agonist	clonidine	(clonidine	hydrochloride,	266.55	g	mol–1;	Sigma-Aldrich)	was	administered	i.p.	at	a	dose	of	50	µg	kg–1	of	body	weight.	We	used	0.9%	NaCl	(saline)	in	H2O	as	a	vehicle	and	for	control	infusions.	Both	vehicle	and	drug	solutions	were	stored	in	100	µl	aliquots	at	–20°C	until	use.		
Optogenetic	photostimulation	in	the	event	arena	experiment	The	mice	were	extensively	habituated	to	the	experimental	procedure	of	photostimulation	and	to	flickering	blue	light	for	several	weeks	prior	to	the	optogenetic	photostimulation	test	in	order	to	minimize	the	potential	novelty	of	the	procedure.	Laser	stimulation,	consisting	of	25	Hz	of	twenty	5-ms	pulses	of	473-nm	light,	delivered	every	5	s	(average	stimulation	rate:	4	Hz)	for	the	duration	of	5	min	(Fig.	4b),	was	performed	in	home	cages	using	two	blue	solid-state	diode	pumped	lasers	(18-19	mW,	Laser	2000)	connected	to	either	a	dual	fibre	optic	patch	cord	(for	VTA;	0.22	NA,	200	µm	core	diameter;	Doric	Lenses)	or	two	single	fibre	optic	patch	cords	(for	LC;	0.22	NA,	200	µm).	Both	lasers	were	synchronously	controlled	using	custom-built	LabVIEW	software.	
	
Extracellular	recording	in	a	novelty	exploration	paradigm	
Apparatus	and	light	stimulation:	Unit	activity	was	recorded	extracellularly	using	the	previously	implanted	custom-built	screw-driven	microdrive	consisting	of	a	200	µm	optic	fibre	surrounded	by	four	tetrodes	(an	‘optetrode’)	that	protruded	400-800	µm	
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beyond	the	fibre	tip54.	Signals	were	fed	through	a	16	channel	unity	gain	headstage	amplifier	(Axona),	band-pass	filtered	at	300-5000	Hz,	amplified	1	k-40	k	times,	digitized	at	50	kHz	and	stored	for	subsequent	analysis.	Spike	capturing	was	done	on-line	using	amplitude	threshold..	Recorded	neurons	were	identified	as	TH+	using	Cre-dependent	ChR2	expression	and	low-frequency	light	stimulation55.	Laser	stimulation	was	performed	using	a	blue	solid-state	diode	pumped	laser	(473	nm,	Laser	2000)	connected	to	a	fibre	optic	patch	cord	(0.22	NA,	200	µm	core	diameter),	and	controlled	with	the	data	capturing	software	(Axona).	Epochs	of	60	light	pulses	(1	Hz,	5	ms	pulse	duration)	at	different	light	intensities	(0.1-20	mW)	were	then	administered	and	each	tetrode	was	screened	for	light-evoked	spikes.	Spikes	were	classified	as	‘light-evoked’	if	their	latency	from	the	onset	of	the	light	pulse	was	between	0	and	15	ms,	all	other	spikes	being	classified	as	‘spontaneous’.	Units	were	classified	as	light-responsive	if:	(a)	a	cell	fired	a	light-evoked	spike	in	response	to	more	than	one	third	of	light	pulses,	(b)	the	shape	of	the	mean	light-evoked	waveform	of	a	unit	closely	resembled	the	spontaneous	waveform	of	the	same	unit.	Units	with	basal	firing	rates	above	20	Hz	were	excluded	from	this	analysis	because	of	intrinsically	high	probability	of	spiking	within	the	15	ms	window	after	the	light	pulse.		
Novelty	exploration:	Two	weeks	after	surgery,	the	implanted	mice	underwent	5	days	of	habituation	to	the	experimental	apparatus	and	the	familiar	environment.	Following	habituation,	mice	underwent	daily	screening	trials	for	light-responsive	neurons.	If	no	light-responsive	cells	were	found,	the	mouse	was	allowed	to	explore	the	familiar	environment	for	5	min	and	was	then	unplugged.	If	one	or	more	recording	channels	showed	a	light-responsive	unit,	the	mouse	was	subjected	to	an	‘exploration’	trial	after	a	10	min	delay	(Fig.	2b).	The	mouse	might	first	be	placed	in	the	novel	environment	for	5	min,	followed	by	25	min	in	the	home	cage	and	5	min	in	the	familiar	environment;	alternatively,	the	order	of	novel	and	familiar	exploration	was	reversed	(in	a	counterbalanced	manner).	The	novelty	substrates	used	were	the	same	as	the	ones	used	in	the	event	arena	tasks.	Baseline	recording	was	performed	between	two	exploration	trials.	These	particular	time	delays	were	chosen	in	order	to	mimic	timing	used	in	the	event	arena	experiments,	where	there	was	a	30	min	delay	between	memory	encoding	and	novelty	exploration.	The	light-sensitive	unit	was	again	confirmed	in	home	cage	with	1	Hz	light	stimulation.	The	microdrive	was	advanced	by	~40	µm	at	the	end	of	daily	session	to	ensure	that	recordings	are	made	from	a	different	population	of	neurons.	
Recording	and	analysis:	Recorded	spikes	were	clustered	using	Klusterkwik	1.5	
20	
unsupervised	clustering	algorithm	(http://klusta-team.github.io/klustakwik/)	based	on	their	energy	and	first	principal	component	of	the	waveform.	Clusters	were	then	corrected	manually	using	Klusters	spike	sorting	software	(http://neurosuite.sourceforge.net/),	based	on	several	additional	parameters	(width	of	waveform,	amplitude,	time	at	peak,	auto-	and	cross-correlograms).	Data	were	analysed	using	Matlab	R2012a	(MathWorks).	Firing	patterns	were	characterised	in	terms	of	firing	rate,	rate	of	burst	events	and	firing	rate	of	spikes	within	bursts.	Bursts	were	defined,	using	classic	criteria56,	as	trains	of	2	or	more	spikes	with	an	interspike	interval	of	less	than	80	ms,	followed	by	an	interspike	interval	of	more	than	160	ms.	For	comparison	of	novelty	modulation	in	VTA-TH+	and	LC-TH+	neurons,	firing	rates	of	individual	neurons	in	the	novel	compartment	were	binned	in	10-s	bins	and	normalised	to	the	average	home	cage	firing	rate	of	all	identified	neurons	in	respective	brain	areas.	For	additional	analysis	of	the	novelty	modulation,	binned	firing	rates	of	individual	neurons	in	the	novel	environment	were	z-scored	to	their	respective	firing	rates	in	the	familiar	compartment.			
Anatomical	tract	tracing	Under	deep	pentobarbital	anesthesia	(100	mg	kg–1	of	body	weight,	i.p.),	the	mice	were	fixed	transcardially	with	4%	paraformaldehyde	in	0.1	M	sodium	phosphate	buffer	(PB),	pH	7.2,	post-fixed	in	the	same	fixative	for	24	h,	and	placed	in	30%	sucrose	in	PB.	Sections	of	fixed	brains	(30	µm	in	thickness)	were	prepared	using	a	freezing	microtome	(SM2000R,	Leica	Microsystems)	for	immunohistochemistry.	
Immunofluorescence:	Antibodies	used	included:	goat	anti-GFP57,	guinea-pig	anti-NET58	and	mouse	anti-TH	(AB152,	Millipore).	eYFP	was	visualized	by	anti-GFP	immunostaining.	All	immunohistochemical	incubations	were	done	at	room	temperature.	Sections	were	incubated	successively	with	10%	normal	donkey	serum	for	20	min,	a	mixture	of	primary	antibodies	overnight	(1	μg	ml–1),	and	a	mixture	of	Alexa	Fluor	488-,	Cy3-,	or	Cy5-labeled	species-specific	secondary	antibodies	(Invitrogen;	Jackson	ImmunoResearch)	for	2	h	at	a	dilution	of	1:200.	
Fluorescent	in	situ	hybridization:	Brains	were	freshly	obtained	under	deep	diethyl	ether	anaesthesia	and	immediately	frozen	in	powdered	dry	ice.	Fresh-frozen	sections	(20	µm)	were	cut	on	a	cryostat	(CM1900,	Leica	Microsystems).	All	sections	were	mounted	on	silane-coated	glass	slides.	Mouse	cDNA	fragments	of	TH	(bases	1-1025;	GenBank	
21	
accession	number,	AY855842),	and	NET	(bases	124-814,	MMU76306)	were	subcloned	into	the	pBluescript	II	plasmid	vector.	Digoxigenin-	or	fluorescein-labeled	cRNA	probes	were	transcribed	in	vitro	for	fluorescent	in	situ	hybridization59.		
Image	acquisition	and	data	analysis:	Images	were	taken	with	a	confocal	laser-scanning	microscope	(FV1200,	Olympus)	equipped	with	diode	laser	lines,	and	UPlanSApo	(20×,	NA	0.75)	and	PlanApoN	(60×,	NA	1.4,	oil-immersion)	objective	lenses	(Olympus).	To	avoid	cross	talk	between	multiple	fluorophores,	Alexa	Fluor	488,	Cy3,	and	Alexa	Fluor	647	fluorescent	signals	were	acquired	sequentially	using	the	473,	559,	and	647	nm	excitation	laser	lines,	respectively.	All	images	show	single	optical	sections.		For	quantification	of	anterograde	tracing,	we	obtained	images	with	a	20×	objective	and	then	created	images	of	the	entire	hippocampus	with	a	Fluoview	image	stitching	software	(Olympus).	For	analysis,	the	separate	colour	components	were	converted	to	greyscale,	and	the	area	of	eYFP-	and	TH-positive	elements	were	measured	with	Integrated	Morphometry	Analysis	module	(MetaMorph	software,	Molecular	Devices).			
Ex	vivo	hippocampal	electrophysiology	
Hippocampal	slice	preparation:	300	µm	thick	coronal	slices	containing	the	hippocampus	were	cut	from	Th-Cre	transgenic	mice52	expressing	AAV2	ChR2-eYFP	in	LC	(8-12	weeks)	in	low	light	conditions	to	prevent	unwanted	ChR2	activation.	Animals	were	anesthetized	under	1.5-2%	isoflurane,	and	the	brains	removed	and	blocked	following	rapid	decapitation.	Hippocampal	slices	were	prepared	using	a	vibratome	(VT	1000S,	Leica	Microsystems)	in	ice	cold	N-Methyl-d-Glucosamine	(NMDG)	ringer	solution	(in	mM):	5	NaCl,	57	NMDG,	37.5	Na-Pyruvate,	12.5	Na-Lactate,	5	Na-Ascorbate,	2.5	KCl,	1.25	NaH2PO4,	25	NaHCO3,	25	Glucose,	10	MgSO4·7H20,	0.5	CaCl2·2H20,	the	pH	was	set	between	7.3	and	7.4	using	12	N	HCl,	the	osmolarity	was	adjusted	as	needed	to	315	mOsm	using	glucose	and	the	solution	was	bubbled	with	95%	O2	and	5%	CO2	gas.	Slices	were	maintained	in	NMDG	ringer	at	room	temperature	for	no	longer	than	15	min	and	then	transferred	to	artificial	cerebral	spinal	fluid	(aCSF)	(in	mM):	125	NaCl,	2.5	KCl,	1.25	NaH2PO4,	1.3	MgCl2,	2	CaCl2,	25	NaHCO3,	and	25	dextrose	continuously	bubbled	with	95%	O2	and	5%	CO2	gas,	where	they	were	kept	up	to	6	h,	protected	from	light,	for	experimentation.	One	slice	per	animal	was	used.	
Ex	vivo	whole-cell	recordings:	Slices	were	transferred	to	a	submersion	recording	chamber	and	were	perfused	with	aCSF	at	a	rate	of	1-2	ml	min-1	at	26-29°C.	EPSC	recordings	were	performed	with	GABAA	receptor	antagonist	picrotoxin	(602.58	g	mol–1;		
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Sigma-Aldrich)	at	a	concentration	of	50	µM	and	D2	receptor	antagonist	eticlopride	(Eticlopride	hydrochloride,	377.31	g	mol–1;		Sigma-Aldrich)	at	a	concentration	of	100	nM	in	the	bath.	A	borosilicate	glass	electrode	(3-5	MΩ),	pulled	with	a	horizontal	pipet	puller	(P-97),	was	filled	with	Cs-methanesulfonate	pipet	solution	(in	mM):	110	CsMeSO3,	15	CsCl,	8	NaCl,	2	EGTA,	10	HEPES,	3	QX-314,	2	ATP	and	0.3	GTP	adjusted	to	295	mOsm	and	pH	7.3.	Whole-cell	pyramidal	cell	recordings	from	area	CA1	were	acquired	using	a	combination	of	visualized	and	blind	patch	techniques.	Cells	were	held	at	–60	mV	using	a	multiclamp	700B	amplifier	(Molecular	Devices).	A	bipolar	stimulating	electrode	(FHC)	was	placed	in	the	stratum	radiatum	region	of	dorsal	CA1	within	100-200	µm	of	the	recording	electrode	and	stimulation	(delivered	at	a	rate	of	0.2	Hz)	was	set	to	elicit	current	responses	of	50-150	pA.	Data	was	acquired	and	analysed	automatically	using	P-Clamp	10	(Molecular	Devices).	Recordings	were	discarded	if	the	series	resistance	varied	by	more	than	20%	or	if	the	initial	holding	current	exceeded	70	pA.	Following	a	5	min	baseline	acquisition,	hippocampal	slices	were	given	a	470-nm	light	stimulus	[consisting	of	three	trains	delivered	every	2	min,	of	sixty	5-ms	pulses,	applied	at	18	Hz	(Extended	Data	Fig.	7b)]	through	the	40×	objective	lenses.	Following	the	light	stimulus,	baseline	stimulation	resumed.		
Ex	vivo	field	recordings:	Slices	were	transferred	to	a	submersion	chamber	and	were	perfused	with	aCSF	at	a	rate	of	~2	ml	min-1	at	29-31°C.	Field	recordings	from	the	stratum	radiatum	of	dorsal	CA1	were	acquired	using	a	borosilicate	glass	electrode	(1-3	MΩ)	filled	with	aCSF.	A	bipolar	stimulating	electrode	was	also	placed	in	the	stratum	radiatum	of	CA1	within	100-200	µm	of	the	recording	electrode	and	stimulation	(one	stimulus	every	30	s)	was	set	to	elicit	a	fEPSP	slope	that	was	~50%	of	the	maximum	value.	A	stable	15	min	baseline	was	obtained,	followed	by	10	more	min	of	baseline	stimulation	with	or	without	simultaneous	optogenetic	stimulation	of	LC-TH+	axons.	Photostimulation	consisting	of	four	trains,	at	a	1	s	interval,	consisting	of	four	10-ms	pulses	of	470-nm	light	at	16	Hz,	delivered	every	30	s	for	the	duration	of	10	min	(Extended	Data	Fig.	7c),	were	applied	through	the	10×	objective	(directly	before	the	Schaffer	collateral	stimulus).	After	the	25	min	baseline,	a	weak	theta-burst	tetanus	was	applied	consisting	of	four	trains,	at	a	100	ms	interval,	consisting	of	3	pulses	at	50	Hz	(12	pulses	in	total).	Baseline	stimulation	then	resumed	as	described	above	for	45	min.	Every	2	traces	were	averaged	to	reduce	variability.	Data	was	acquired	and	analysed	automatically	using	P-Clamp	10.		
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Ex	vivo	pharmacology:	Where	indicated,	the	following	drugs	were	bath	applied:	α-adrenoceptor	antagonist	prazosin	(prazosin	hydrochloride,	419.86	g	mol–1;		Sigma-Aldrich)	at	a	concentration	of	30	μM,	b-adrenoceptor	antagonist	propranolol	[(S)-(–)-propranolol	hydrochloride,	295.80	g	mol–1;		Sigma-Aldrich]	at	a	concentration	of	30	μM,	D1/D5	receptor	antagonist	SCH	39166	(SCH	39166	hydrochloride,	394.73	g	mol–1;	Tocris)	at	a	concentration	of	100	nM	(intracellular	recordings,	n	=	2),	and	D1/D5	receptor	antagonist	SCH	23390	(SCH	23390	hydrochloride,	324.24	g	mol–1;	Tocris)	at	a	concentration	of	100	nM	(intracellular	recordings,	n	=	3)	or	1	µM	(extracellular	recordings).		
Acute	extracellular	recordings	in	anaesthetised	mice	Anaesthesia	was	induced	using	isoflurane	for	LC	optrode	recording	as	described	above	or	4.8%	chloral	hydrate	for	VTA	recording	(induction:	480	mg	kg–1	body	weight,	i.p.;	maintenance:	120	mg	kg–1	body	weight,	i.p.).	Recordings	were	made	using	a	125	µm	1	MΩ	tungsten	electrode	(A-M	systems).	This	electrode	was	connected	to	a	differential	AC	amplifier	(A-M	Systems),	signals	were	band-pass	filtered	at	300	Hz-5	kHz,	amplified	10	K	times	and	digitized	at	20	kHz.	Spiking	activity	was	defined	as	spikes	that	exceed	5	standard	deviations	from	the	mean	value	of	the	baseline	signal	[1	min	before	laser	stimulation	(LC)	or	drug	infusion	(VTA)].	Multi-unit	activity	in	each	trace	was	then	normalised	to	the	pre-stimulation	(LC)	or	pre-infusion	(VTA)	baseline.	
LC	optrode	recording:	The	tungsten	electrode	was	coupled	to	an	optic	fibre	(0.22	NA,	200	µm	core	diameter)	(an	‘optrode’).	This	optrode	was	positioned	above	LC	(AP,	–5.45	mm;	ML,	1.00	mm;	and	DV,	–2.80	mm),	and	was	then	gradually	in	lowered	in	50	µm	increments	until	multi-unit	activity	was	observed.	Laser	stimulation	was	performed	using	a	green	solid-state	diode	pumped	laser	(532	nm,	Laser	2000)	with	10-20	mW	output	from	the	fiber.	For	quantification	of	eArch3.0	recordings,	baseline	was	measured	over	30	s	before	the	start	of	illumination	(Pre),	level	of	inhibition	was	measured	over	5	min	light	on	period	(LC-ON),	rebound	activity	was	measured	over	1	min	after	the	end	of	illumination	(Rebound),	post-inhibition	baseline	was	measured	4-5	min	after	the	end	of	illumination	(Post).		
VTA	recording	with	pharmacology:	The	drug	cannula	(33	gauge,	Plastics	One)	was	positioned	in	the	VTA	at	14°	angle	to	sagittal	plane	(AP,	–3.52	mm;	ML,	0.48	mm;	and	DV,	–4.40	mm)	and	the	recording	electrode	was	positioned	vertically	at	the	boundary	of	
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the	VTA.	For	intra-VTA	microinjection	of	lidocaine,	infusion	parameters	were	the	same	as	those	used	in	the	behavioural	experiment	as	described	above.	For	quantification,	pre-infusion	baseline	was	measured	over	30	s	before	the	start	of	infusion	(Pre),	level	of	inhibition	was	measured	3-8	min	after	the	start	of	infusion	(Lid)	-	the	period	that	corresponds	to	novelty	exploration,	and	post-inhibition	baseline	was	measured	17-18	min	after	the	start	of	injection	(Post).			
	
Statistics,	data	presentation	and	data	deposition	Statistical	analyses	were	performed	using	SPSS	version	19	(IBM).	All	data	are	expressed	as	mean	±	s.e.m.	Statistical	significance	was	always	determined	by	ANOVAs,	prior	to	orthogonal	comparisons	where	possible	or	Tukey	HSD	tests	as	appropriate	to	correct	for	multiple	comparisons,	paired	t-tests	and	one-sample	t-tests.	All	statistical	tests	were	two-tailed.	Analysis	of	probe	test	performance	was	done	on	the	basis	on	the	‘%	correct	dig	time’	score.	In	the	pharmacological	inactivation	experiment	(Fig.	6),	three	animals	that	persistently	failed	to	show	any	novelty-induced	memory	enhancement	in	all	control	conditions	[all	24-h	PT	scores	(%	correct	dig)	in	the	‘novelty	with	vehicle’	condition	at	below	chance	level,	i.e.	<	20%]	were	eliminated	from	the	whole	dataset	prior	to	statistical	analysis	(leaving	n	=	15).	The	rationale	was	that	it	is	not	possible	to	measure	the	impact	of	pharmacological	manipulations	on	the	novelty	effect	in	animals	that	are	not	susceptible	to	it,	the	existence	of	the	novelty	effect	having	been	established	in	the	first	cohort	of	mice	(Fig.	1b).	All	source	data	for	the	preparation	of	graphs	and	statistical	analysis	is	presented	online.	All	other	relevant	data	that	support	the	conclusions	of	the	study	are	available	from	the	authors	on	request.		51	 Lindeberg,	J.	et	al.	Transgenic	expression	of	Cre	recombinase	from	the	tyrosine	hydroxylase	locus.	Genesis	40,	67–73	(2004).	52	 Savitt,	J.	M.,	Jang,	S.	S.,	Mu,	W.,	Dawson,	V.	L.	&	Dawson,	T.	M.	Bcl-x	is	required	for	proper	development	of	the	mouse	substantia	nigra.	J.	Neurosci.	25,	6721–6728	(2005).	53	 Franklin,	K.	B.	J.	&	Paxinos,	G.	The	Mouse	Brain	in	Stereotaxic	Coordinates	3rd	ed	(Academic	Press:	San	Diego,	2007).	54	 Anikeeva,	P.	et	al.	Optetrode:	a	multichannel	readout	for	optogenetic	control	in	freely	moving	mice.	Nat.	Neurosci.	15,	163–170	(2012).	55	 Cohen,	J.	Y.,	Haesler,	S.,	Vong,	L.,	Lowell,	B.	B.	&	Uchida,	N.	Neuron-type-specific	signals	for	reward	and	punishment	in	the	ventral	tegmental	area.	Nature	482,	85–88	(2012).	
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Figure	Legends	
 
Figure	1	|	Novelty	exploration	after	memory	encoding	enhances	memory	
retention.	a,	Everyday	spatial	memory	task	in	event	arena.	Mice	[n=13;	100	sessions	(Ss)]	acquired	stable	performance	(S26-S100:	F14,168=1.68,	P>0.05).	Non-encoding	control	session	performance	(S63,	orange	arrow)	dropped	to	59.6%	(S61-S65:	
F4,48=3.63,	P<0.05;	S63:	t-test	vs.	chance,	t12<1).	Green	circles,	5S	average;	white	circles,	1S	average;	Pre,	pre-training.	b,	Memory	at	1h	(probe	test)	declined	to	chance	at	24h	(1h	vs.	24h:	t12=2.94,	P<0.05;	1h:	t12=4.44,	P<0.001).	Novelty	30min	after	encoding	resulted	in	memory	at	24h	(No	novelty	vs.	Novelty:	t12=2.24,	P<0.05;	Novelty:	t12=3.17,	
P<0.01).	c,	Blockade	of	hippocampal	D1/D5	receptor	(SCH)	but	not	β-adrenoceptors	(Prop)	during	novelty	abolished	24h	memory	(F2,24=3.83,	P<0.05;	Vehicle:	t12=4.38,	
P<0.001;	Prop:	t12=3.33,	P<0.01).	HPC,	hippocampus;	Prop,	propranolol;	SCH,	SCH23390.	**P<0.01,	***P<0.001	vs.	chance.	Dashed	lines,	chance.	Means±s.e.m.		
Figure	2	|	LC-TH+	neurons	show	stronger	modulation	by	novelty	than	VTA-TH+	
neurons.	a,	Viral	injection	and	optetrode	implantation.	Putative	VTA-TH+	and	LC-TH+	neurons	responded	to	blue	light	(blue).	b,	Behavioural	protocol.	c,	Raster	plot	of	VTA-TH+	(top)	and	LC-TH+	neurons	(bottom)	in	familiar	(left)	and	novel	(right)	environments.	FR,	firing	rate.	d,	FRs	of	VTA-TH+	(n=15	neurons,	5	mice)	and	LC-TH+	(n=10	neurons,	3	mice)	neurons	were	higher	in	the	novel	environment	(VTA-TH+:	
t14=4.30,	P<0.01;	LC-TH+:	t9=3.46,	P<0.01).	Dashed	lines,	baseline.	e,	LC-TH+	neurons	showed	stronger	modulation	by	novelty	than	VTA-TH+	neurons	(Brain	Area×Condition	interaction,	F1,23=15.20,	P<0.001).	LC-TH+	but	not	VTA-TH+	neurons	displayed	habituation	to	novelty	(LC	novel,	F29,261=1.70,	P<0.05;	VTA	novel,	F29,406=1.23,	P>0.05).	**P<0.01,	paired	t-test.	Means±s.e.m. 	
Figure	3	|	TH+	axons	in	the	hippocampus	originate	from	LC-TH+	neurons.	a–d,	Representative	coronal	sections	show	overall	distribution	of	eYFP+	axons	from	VTA	(a)	and	LC	(c)	in	dorsal	hippocampus.	Triple	immunofluorescence	for	eYFP	(green),	TH	(red)	and	NET	(blue)	shows	co-labelling	of	eYFP+	VTA	axons	with	TH	(b,	top)	but	not	with	NET	(b,	bottom;	arrows),	co-labelling	of	eYFP+	LC	axons	with	TH	(d,	top)	and	NET	(d,	bottom).	e,	f,	Quantification	of	area	occupied	by	eYFP	and	TH	double-positive	axons	(e),	and	the	ratio	of	eYFP	and	TH	double-positive	axons	relative	to	all	TH+	axons	(f)	in	
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CA1	,	CA3,	and	DG	(n=9	slices,	3	mice/group).	Both	measures	indicate	stronger	TH+	projections	from	LC	than	from	VTA	in	CA1	(Area:	t16=7.4,	P<0.001;	Ratio:	t16=104.1,	
P<0.001),	CA3	(Area:	t16=11.7,	P<0.001;	Ratio:	t16=59.0,	P<0.001)	and	DG	(Area:	
t16=10.8,	P<0.001;	Ratio:	t16=76.4,	P<0.001).	***P<0.001,	paired	t-test.	Means±s.e.m.			
Figure	4	|	Optogenetic	activation	of	LC-TH+	neurons	enhances	memory	
persistence.		a,	Viral	injection,	optic	fibre	and	drug	cannulae	implantations.	Th-Cre	mice	injected	with	a	Cre-inducible	ChR2-eYFP	AAV	(ChR2+,	n=8)	or	a	control	eYFP	AAV	(ChR2–,	n=6)	into	LC	and	VTA.	b,	Optogenetic	burst	protocol	used	in	the	event	arena.	c,	Design	for	optogenetic	mimicry	experiment.	d,	Left,	LC-TH+	neuron	photostimulation	(LC-ON)	30min	after	encoding	enhanced	24h	memory	in	ChR2+	animals	but	not	in	ChR2–	controls	(Group×Condition	interaction,	F1,12=5.66,	P<0.05;	ChR2+	in	LC-ON	vs.	chance:	t7=4.38,	P<0.01).	Right,	VTA-TH+	neuron	photostimulation	(VTA-ON)	caused	a	trend	for	enhanced	memory	that	did	not	differ	between	groups	(Group×Condition	interaction,	F1,12=0.33,	P=0.58;	ChR2+	in	VTA-ON:	t7=2.22,	P=0.062;	ChR2–	in	VTA-ON:	
t5=1.56,	P=0.18).	e,	Design	for	optogenetic	LC	activation	experiment	with	pharmacological	interventions.	f,	Blockade	of	hippocampal	D1/D5	receptor	(SCH)	but	not	β-adrenoceptors	(Prop)	during	LC-TH+	neuron	photostimulation	abolished	the	effect	of	LC	photostimulation	on	memory	persistence	in	ChR2+	mice	(Group	effect,	
F1,12=5.01,	P<0.05;	Condition	effect	in	ChR2+,	F3,21=3.18,	P<0.05;	in	ChR2–:	F3,15<1).	ChR2+	mice	showed	good	memory	with	post-encoding	LC-ON	in	presence	of	vehicle	or	Prop,	but	not	in	presence	of	SCH,	or	without	light	stimulation	(Orthogonal	comparison:	
F1,21=9.23,	P<0.01;	LC-ON	with	Vehicle	in	ChR2+:	t7=3.07,	P<0.05;	LC-ON	with	Prop	in	ChR2+:	t7=2.41,	P<0.05).	Prop,	propranolol;	SCH,	SCH23390.	*P<0.05,	**P<0.01	vs.	chance.	Dashed	lines,	chance.	Means±s.e.m.		
Figure	5	|	Optogenetic	activation	of	LC-TH+	axons	enhances	hippocampal	synaptic	
function.	a,	Hippocampal	slice	physiology.	Orange	line,	slice	plane.	b,	Left,	potentiation	of	Schaffer	collateral	(SC)-evoked	EPSCs	from	CA1	pyramidal	neurons	after	strong	light	activation	(blue)	of	hippocampal	LC-TH+	axons	(Light-ON,	n=5)	was	unaffected	by	adrenoceptor	antagonists	(Light-ON,	Praz/Prop,	n=4)	but	blocked	by	D1/D5	receptor	antagonist	(Light-ON,	SCH,	n=5)	(Conditions×Time	interaction,	F7.8,	42.8=2.50,	P<0.05,	Greenhouse-Geisser	correction).	Middle,	exemplar	EPSCs	from	CA1	pyramidal	neurons.	Dashed	lines,	baseline	EPSCs;	Continuous,	EPSCs	30-35min	after	light	onset.	Right,	mean	
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EPSCs	35min	after	light	onset,	showing	effect	of	SCH	but	no	effect	of	Praz/Prop	(F2,11=7.20,	P<0.05).	c,	Left,	fEPSP	responses	to	weak	theta-burst	stimulation	(arrow)	with	or	without	optogenetic	activation	of	hippocampal	LC-TH+	axons	(blue).	No	synaptic	potentiation	without	theta-burst	[Light-ON	(no	LTP),	n=6],	but	with	it,	an	increase	in	synaptic	strength	lasting	>45min	(Light-OFF+LTP,	n=6)	that	was	significantly	enhanced	by	a	weak	physiologically	relevant	optogenetic	stimulation	of	LC-TH+	axons	(Light-ON+LTP,	n=11).	SCH	blocked	enhancement	of	LTP	(Light-ON+LTP	with	SCH,	n=5)	(Conditions×Time	interaction,	F19.5/155.8=3.01,	P<0.001).	Middle,	fEPSPs:	baseline	(dashed	lines)	and	40-45min	after	theta-burst	stimulation	(continuous	lines).	Right,	mean	fEPSP	slopes	45min	after	theta-burst	stimulation,	shows	blockade	of	optogenetic	augmentation	of	LTP	by	SCH	(F3,24=17.00,	P<0.001).	Praz,	prazosin;	Prop,	propranolol;	SCH,	SCH23390	or	SCH39166	(see	Methods).	ns,	not	significant.	*P<0.05,	**P<0.01,	Tukey	HSD	test.	Means±s.e.m.	
	
Figure	6	|	Pharmacological	inhibition	of	VTA	has	no	impact	on	the	novelty	effect.		
a,	Microinfusion	of	lidocaine	(Lid)	into	VTA	blocks	multi-unit	activity	(example	trace	and	population	data;	n=8	traces,	4	mice;	Pre	vs.	Lid:	t7=8.42,	P<0.001;	Pre	vs.	Post:	
t7=1.42,	P>0.05).	Magenta	box,	novelty	period.	b,	Lidocaine	into	the	VTA	before	novelty	had	no	effect	on	memory	enhancement	(n=15	mice)	(Vehicle	vs.	Lid:	t14<1;	Vehicle	vs.	chance:	t14=2.95,	P<0.05;	Lid:	t14=2.19,	P<0.05).	c,	Systemic	injection	of	a2-adrenergic	receptor	agonist	clonidine	before	novelty	abolished	novelty	effect	(F2,28=7.70,	P<0.01;	Novelty	with	Vehicle:	t14=4.62,	P<0.001).	ns,	not	significant.	*P<0.05,	***P<0.001.	Dashed	lines,	chance.	Means±s.e.m.		
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